Huang, Feng-Ting <br/><br/>
MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.  [electronic resource] 

 -  Digestive diseases and sciences  04 2017 
 - 944-957 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-2568 
<br/><br/><label>Standard No.: </label>10.1007/s10620-017-4472-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Animals<br/>Biomarkers, Tumor--genetics<br/>Carcinoma, Pancreatic Ductal--genetics<br/>Cell Line, Tumor<br/>Disease Progression<br/>Female<br/>Humans<br/>MAP Kinase Kinase Kinases--antagonists & inhibitors<br/>MAP Kinase Signaling System--physiology<br/>Male<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>MicroRNAs--genetics<br/>Middle Aged<br/>NF-kappa B--genetics<br/>Pancreatic Neoplasms--genetics<br/>Xenograft Model Antitumor Assays--methods